AngioDynamics, Inc. (ANGO)
USD 8.93
(-3.56%)
USD 8.93
(-3.56%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 154.69 Million USD | -11.22% |
| 2023 | 174.24 Million USD | 5.14% |
| 2022 | 165.73 Million USD | 5.7% |
| 2021 | 156.78 Million USD | 4.34% |
| 2020 | 150.27 Million USD | -21.68% |
| 2019 | 191.87 Million USD | 8.48% |
| 2018 | 176.87 Million USD | 0.4% |
| 2017 | 176.16 Million USD | 1.26% |
| 2016 | 173.96 Million USD | -1.65% |
| 2015 | 176.88 Million USD | -1.65% |
| 2014 | 179.86 Million USD | 6.43% |
| 2013 | 168.98 Million USD | 34.16% |
| 2012 | 125.95 Million USD | 0.09% |
| 2011 | 125.84 Million USD | -0.88% |
| 2010 | 126.96 Million USD | 5.75% |
| 2009 | 120.06 Million USD | 17.04% |
| 2008 | 102.58 Million USD | 55.04% |
| 2007 | 66.16 Million USD | 45.35% |
| 2006 | 45.52 Million USD | 36.38% |
| 2005 | 33.37 Million USD | 29.36% |
| 2004 | 25.8 Million USD | 29.9% |
| 2003 | 19.86 Million USD | 27.67% |
| 2002 | 15.55 Million USD | 41.79% |
| 2001 | 10.97 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 40.06 Million USD | -13.59% |
| 2024 Q3 | 32.57 Million USD | -19.09% |
| 2024 FY | 141.65 Million USD | -18.71% |
| 2024 Q4 | 35.94 Million USD | 10.34% |
| 2024 Q2 | 40.26 Million USD | 0.5% |
| 2023 Q1 | 42.3 Million USD | -8.93% |
| 2023 Q2 | 45.07 Million USD | 6.55% |
| 2023 Q3 | 40.5 Million USD | -10.15% |
| 2023 Q4 | 46.35 Million USD | 14.46% |
| 2023 FY | 174.24 Million USD | 5.14% |
| 2022 FY | 165.73 Million USD | 5.7% |
| 2022 Q4 | 46.45 Million USD | 20.4% |
| 2022 Q3 | 38.58 Million USD | -4.86% |
| 2022 Q2 | 40.55 Million USD | 1.04% |
| 2022 Q1 | 40.13 Million USD | -5.15% |
| 2021 Q4 | 42.32 Million USD | 9.84% |
| 2021 Q3 | 38.53 Million USD | -4.09% |
| 2021 FY | 156.78 Million USD | 4.34% |
| 2021 Q2 | 40.17 Million USD | 12.33% |
| 2021 Q1 | 35.76 Million USD | 18.38% |
| 2020 FY | 150.27 Million USD | -21.68% |
| 2020 Q4 | 30.21 Million USD | -25.03% |
| 2020 Q3 | 40.29 Million USD | -3.0% |
| 2020 Q2 | 41.54 Million USD | 8.71% |
| 2020 Q1 | 38.21 Million USD | -25.94% |
| 2019 Q2 | 49.1 Million USD | 10.44% |
| 2019 FY | 191.87 Million USD | 8.48% |
| 2019 Q1 | 44.46 Million USD | -6.32% |
| 2019 Q4 | 51.6 Million USD | 10.52% |
| 2019 Q3 | 46.69 Million USD | -4.92% |
| 2018 Q2 | 42.73 Million USD | 3.64% |
| 2018 Q1 | 41.22 Million USD | -2.61% |
| 2018 FY | 176.87 Million USD | 0.4% |
| 2018 Q4 | 47.46 Million USD | 4.44% |
| 2018 Q3 | 45.44 Million USD | 6.36% |
| 2017 FY | 176.16 Million USD | 1.26% |
| 2017 Q2 | 45.01 Million USD | -0.05% |
| 2017 Q3 | 43.79 Million USD | -2.71% |
| 2017 Q4 | 42.33 Million USD | -3.33% |
| 2017 Q1 | 45.03 Million USD | 8.57% |
| 2016 Q3 | 43.48 Million USD | -5.13% |
| 2016 Q1 | 43.17 Million USD | -5.23% |
| 2016 FY | 173.96 Million USD | -1.65% |
| 2016 Q2 | 45.83 Million USD | 6.16% |
| 2016 Q4 | 41.47 Million USD | -4.62% |
| 2015 FY | 176.88 Million USD | -1.65% |
| 2015 Q1 | 46.14 Million USD | -2.91% |
| 2015 Q4 | 45.55 Million USD | 20.36% |
| 2015 Q3 | 37.85 Million USD | -20.57% |
| 2015 Q2 | 47.65 Million USD | 3.27% |
| 2014 Q3 | 45.63 Million USD | 1.57% |
| 2014 Q1 | 42.48 Million USD | -3.98% |
| 2014 Q4 | 47.53 Million USD | 4.15% |
| 2014 Q2 | 44.93 Million USD | 5.76% |
| 2014 FY | 179.86 Million USD | 6.43% |
| 2013 Q1 | 39.45 Million USD | 26.6% |
| 2013 FY | 168.98 Million USD | 34.16% |
| 2013 Q4 | 44.24 Million USD | 7.38% |
| 2013 Q3 | 41.2 Million USD | -6.55% |
| 2013 Q2 | 44.08 Million USD | 11.73% |
| 2012 Q1 | 32.14 Million USD | -1.3% |
| 2012 FY | 125.95 Million USD | 0.09% |
| 2012 Q4 | 31.16 Million USD | 5.96% |
| 2012 Q3 | 29.41 Million USD | -11.49% |
| 2012 Q2 | 33.23 Million USD | 3.38% |
| 2011 Q2 | 31.53 Million USD | 5.05% |
| 2011 FY | 125.84 Million USD | -0.88% |
| 2011 Q4 | 32.56 Million USD | 2.67% |
| 2011 Q1 | 30.02 Million USD | -14.12% |
| 2011 Q3 | 31.72 Million USD | 0.59% |
| 2010 Q4 | 34.95 Million USD | 15.47% |
| 2010 FY | 126.96 Million USD | 5.75% |
| 2010 Q3 | 30.27 Million USD | -4.22% |
| 2010 Q1 | 30.13 Million USD | -7.83% |
| 2010 Q2 | 31.6 Million USD | 4.9% |
| 2009 FY | 120.06 Million USD | 17.04% |
| 2009 Q1 | 27.45 Million USD | -6.33% |
| 2009 Q4 | 32.69 Million USD | 8.18% |
| 2009 Q3 | 30.22 Million USD | 1.78% |
| 2009 Q2 | 29.69 Million USD | 8.14% |
| 2008 Q2 | 25.45 Million USD | 13.13% |
| 2008 FY | 102.58 Million USD | 55.04% |
| 2008 Q3 | 25.31 Million USD | -0.54% |
| 2008 Q1 | 22.5 Million USD | -6.43% |
| 2008 Q4 | 29.31 Million USD | 15.78% |
| 2007 Q3 | 15.94 Million USD | 11.97% |
| 2007 FY | 66.16 Million USD | 45.35% |
| 2007 Q2 | 14.24 Million USD | 19.44% |
| 2007 Q4 | 24.04 Million USD | 50.78% |
| 2007 Q1 | 11.92 Million USD | -12.35% |
| 2006 Q2 | 10.84 Million USD | 13.93% |
| 2006 Q4 | 13.6 Million USD | 17.83% |
| 2006 Q3 | 11.54 Million USD | 6.47% |
| 2006 Q1 | 9.52 Million USD | -2.42% |
| 2006 FY | 45.52 Million USD | 36.38% |
| 2005 Q4 | 9.75 Million USD | 13.91% |
| 2005 FY | 33.37 Million USD | 29.36% |
| 2005 Q3 | 8.56 Million USD | 6.21% |
| 2005 Q1 | 6.99 Million USD | -7.01% |
| 2005 Q2 | 8.06 Million USD | 15.32% |
| 2004 Q3 | 6.09 Million USD | 0.0% |
| 2004 Q4 | 7.52 Million USD | 23.42% |
| 2004 FY | 25.8 Million USD | 29.9% |
| 2003 FY | 19.86 Million USD | 27.67% |
| 2003 Q4 | 5.83 Million USD | -14.22% |
| 2003 Q3 | 6.8 Million USD | 0.0% |
| 2002 FY | 15.55 Million USD | 41.79% |
| 2001 FY | 10.97 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -174.75% |
| AtriCure, Inc. | 300.37 Million USD | 48.498% |
| Avinger, Inc. | 2 Million USD | -7623.315% |
| Azenta, Inc. | 263.14 Million USD | 41.211% |
| BioLife Solutions, Inc. | 46.75 Million USD | -230.891% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 93.439% |
| Daxor Corporation | 1.1 Million USD | -13919.611% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -1603.91% |
| Femasys Inc. | 691.9 Thousand USD | -22258.401% |
| GlucoTrack, Inc. | -13 Thousand USD | 1190084.615% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -154.162% |
| Hologic, Inc. | 2.22 Billion USD | 93.056% |
| ICU Medical, Inc. | 739.87 Million USD | 79.091% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 96.729% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -825.876% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -21.762% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 129739.903% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 129739.903% |
| Masimo Corporation | 1 Billion USD | 84.584% |
| Microbot Medical Inc. | -106 Thousand USD | 146041.509% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -367.436% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 73.505% |
| Nephros, Inc. | 8.4 Million USD | -1740.547% |
| NovoCure Limited | 381.05 Million USD | 59.403% |
| NEXGEL, Inc. | 619 Thousand USD | -24891.599% |
| NEXGEL, Inc. | 619 Thousand USD | -24891.599% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 27823.656% |
| OraSure Technologies, Inc. | 179.42 Million USD | 13.779% |
| Pro-Dex, Inc. | 14.55 Million USD | -963.143% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 12916.736% |
| Predictive Oncology Inc. | 1.14 Million USD | -13407.239% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -2568.23% |
| QuidelOrtho Corporation | 1.49 Billion USD | 89.648% |
| Repligen Corporation | 315.22 Million USD | 50.925% |
| Sanara MedTech Inc. | 57.13 Million USD | -170.749% |
| STAAR Surgical Company | 252.65 Million USD | 38.77% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 17457.458% |
| Utah Medical Products, Inc. | 30.03 Million USD | -415.008% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 92.584% |
| Jin Medical International Ltd. | 6.78 Million USD | -2180.056% |